866-997-4948(US-Canada Toll Free)

Global Cancer Screening Market Size, Status and Forecast 2022

Published By :

QYResearch

Published Date : Feb 2017

Category :

Cancer

No. of Pages : 109 Pages

Notes:
Production, means the output of Cancer Screening
Revenue, means the sales value of Cancer Screening

This report studies the global Cancer Screening market, analyzes and researches the Cancer Screening development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Abbott
Roche
Fujirebio Diagnostics, Inc.
BioMrieux
Beckman Coulter
Clarient
Siemens
DiaSorin
Qiagen
Xeptagen
Orion Genomics.
Hologic, Inc.
Quest Diagnostics
Oncohealth Corporation
Femasys, Inc.
Biohit Oyj
Sysmex
Immunostics
Alere

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Application, Cancer Screening can be split into
Application 1
Application 2


Table of Contents

Global Cancer Screening Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Screening
1.1 Cancer Screening Market Overview
1.1.1 Cancer Screening Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Screening Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Screening Market by End Users/Application
1.3.1 Application 1
1.3.2 Application 2

2 Global Cancer Screening Competition Analysis by Players
2.1 Cancer Screening Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Abbott
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Screening Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Roche
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Screening Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Fujirebio Diagnostics, Inc.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Screening Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 BioMrieux
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Screening Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Beckman Coulter
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Screening Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Clarient
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Screening Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Siemens
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Screening Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 DiaSorin
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Screening Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Qiagen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Screening Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Xeptagen
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Screening Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Orion Genomics.
3.12 Hologic, Inc.
3.13 Quest Diagnostics
3.14 Oncohealth Corporation
3.15 Femasys, Inc.
3.16 Biohit Oyj
3.17 Sysmex
3.18 Immunostics
3.19 Alere

4 Global Cancer Screening Market Size by Application (2012-2017)
4.1 Global Cancer Screening Market Size by Application (2012-2017)
4.2 Potential Application of Cancer Screening in Future
4.3 Top Consumer/End Users of Cancer Screening

5 United States Cancer Screening Development Status and Outlook
5.1 United States Cancer Screening Market Size (2012-2017)
5.2 United States Cancer Screening Market Size and Market Share by Players (2015-2016)

6 EU Cancer Screening Development Status and Outlook
6.1 EU Cancer Screening Market Size (2012-2017)
6.2 EU Cancer Screening Market Size and Market Share by Players (2015-2016)

7 Japan Cancer Screening Development Status and Outlook
7.1 Japan Cancer Screening Market Size (2012-2017)
7.2 Japan Cancer Screening Market Size and Market Share by Players (2015-2016)

8 China Cancer Screening Development Status and Outlook
8.1 China Cancer Screening Market Size (2012-2017)
8.2 China Cancer Screening Market Size and Market Share by Players (2015-2016)

9 India Cancer Screening Development Status and Outlook
9.1 India Cancer Screening Market Size (2012-2017)
9.2 India Cancer Screening Market Size and Market Share by Players (2015-2016)

10 Southeast Asia Cancer Screening Development Status and Outlook
10.1 Southeast Asia Cancer Screening Market Size (2012-2017)
10.2 Southeast Asia Cancer Screening Market Size and Market Share by Players (2015-2016)

11 Market Forecast by Regions and Application (2017-2022)
11.1 Global Cancer Screening Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.2 EU Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.4 China Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.5 India Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cancer Screening Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Screening Market Size (Value) by Application (2017-2022)
11.3 The Market Drivers in Future

12 Cancer Screening Market Dynamics
12.1 Cancer Screening Market Opportunities
12.2 Cancer Screening Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cancer Screening Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cancer Screening Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Cancer Screening Product Scope
Figure Global Cancer Screening Market Size (2012-2017)
Table Global Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure Global Cancer Screening Market Share by Regions in 2015
Figure United States Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure EU Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure China Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure India Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Figure Global Cancer Screening Market Share by Application in 2015
Figure Cancer Screening Market Size and Growth Rate in Applications 1 (2012-2017)
Figure Cancer Screening Market Size and Growth Rate in Applications 2 (2012-2017)
Figure Cancer Screening Market Size and Growth Rate in Applications 3 (2012-2017)
Table Cancer Screening Market Size (Value) by Players (2015-2016)
Figure Cancer Screening Market Size Share by Players in 2015
Figure Cancer Screening Market Size Share by Players in 2016
Table Abbott Basic Information List
Table Cancer Screening Business Revenue of Abbott (2012-2017)
Figure Abbott Cancer Screening Business Revenue Market Share in 2015
Table Roche Basic Information List
Table Cancer Screening Business Revenue of Roche (2012-2017)
Figure Roche Cancer Screening Business Revenue Market Share in 2015
Table Fujirebio Diagnostics, Inc. Basic Information List
Table Cancer Screening Business Revenue of Fujirebio Diagnostics, Inc. (2012-2017)
Figure Fujirebio Diagnostics, Inc. Cancer Screening Business Revenue Market Share in 2015
Table BioMrieux Basic Information List
Table Cancer Screening Business Revenue of BioMrieux (2012-2017)
Figure BioMrieux Cancer Screening Business Revenue Market Share in 2015
Table Beckman Coulter Basic Information List
Table Cancer Screening Business Revenue of Beckman Coulter (2012-2017)
Figure Beckman Coulter Cancer Screening Business Revenue Market Share in 2015
Table Clarient Basic Information List
Table Cancer Screening Business Revenue of Clarient (2012-2017)
Figure Clarient Cancer Screening Business Revenue Market Share in 2015
Table Siemens Basic Information List
Table Cancer Screening Business Revenue of Siemens (2012-2017)
Figure Siemens Cancer Screening Business Revenue Market Share in 2015
Table DiaSorin Basic Information List
Table Cancer Screening Business Revenue of DiaSorin (2012-2017)
Figure DiaSorin Cancer Screening Business Revenue Market Share in 2015
Table Qiagen Basic Information List
Table Cancer Screening Business Revenue of Qiagen (2012-2017)
Figure Qiagen Cancer Screening Business Revenue Market Share in 2015
Table Xeptagen Basic Information List
Table Cancer Screening Business Revenue of Xeptagen (2012-2017)
Figure Xeptagen Cancer Screening Business Revenue Market Share in 2015
Table Orion Genomics. Basic Information List
Table Cancer Screening Business Revenue of Orion Genomics. (2012-2017)
Figure Orion Genomics. Cancer Screening Business Revenue Market Share in 2015
Table Hologic, Inc. Basic Information List
Table Cancer Screening Business Revenue of Hologic, Inc. (2012-2017)
Figure Hologic, Inc. Cancer Screening Business Revenue Market Share in 2015
Table Quest Diagnostics Basic Information List
Table Cancer Screening Business Revenue of Quest Diagnostics (2012-2017)
Figure Quest Diagnostics Cancer Screening Business Revenue Market Share in 2015
Table Oncohealth Corporation Basic Information List
Table Cancer Screening Business Revenue of Oncohealth Corporation (2012-2017)
Figure Oncohealth Corporation Cancer Screening Business Revenue Market Share in 2015
Table Femasys, Inc. Basic Information List
Table Cancer Screening Business Revenue of Femasys, Inc. (2012-2017)
Figure Femasys, Inc. Cancer Screening Business Revenue Market Share in 2015
Table Biohit Oyj Basic Information List
Table Cancer Screening Business Revenue of Biohit Oyj (2012-2017)
Figure Biohit Oyj Cancer Screening Business Revenue Market Share in 2015
Table Sysmex Basic Information List
Table Cancer Screening Business Revenue of Sysmex (2012-2017)
Figure Sysmex Cancer Screening Business Revenue Market Share in 2015
Table Immunostics Basic Information List
Table Cancer Screening Business Revenue of Immunostics (2012-2017)
Figure Immunostics Cancer Screening Business Revenue Market Share in 2015
Table Alere Basic Information List
Table Cancer Screening Business Revenue of Alere (2012-2017)
Figure Alere Cancer Screening Business Revenue Market Share in 2015
Table Global Cancer Screening Market Size by Application (2012-2017)
Figure Global Cancer Screening Market Size by Application in 2011
Figure Global Cancer Screening Market Size by Application in 2012
Figure Global Cancer Screening Market Size by Application in 2013
Figure Global Cancer Screening Market Size by Application in 2014
Figure Global Cancer Screening Market Size by Application in 2015
Figure Global Cancer Screening Market Size by Application in 2016
Table Top Consumer/End Users of Cancer Screening
Figure United States Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Table United States Cancer Screening Market Size by Players (2012-2017)
Figure United States Cancer Screening Market Size Share by Players in 2015
Figure United States Cancer Screening Market Size Share by Players in 2016
Figure EU Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Table EU Cancer Screening Market Size by Players (2012-2017)
Figure EU Cancer Screening Market Size Share by Players in 2015
Figure EU Cancer Screening Market Size Share by Players in 2016
Figure Japan Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Table Japan Cancer Screening Market Size by Players (2012-2017)
Figure Japan Cancer Screening Market Size Share by Players in 2015
Figure Japan Cancer Screening Market Size Share by Players in 2016
Figure China Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Table China Cancer Screening Market Size by Players (2012-2017)
Figure China Cancer Screening Market Size Share by Players in 2015
Figure China Cancer Screening Market Size Share by Players in 2016
Figure India Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Table India Cancer Screening Market Size by Players (2012-2017)
Figure India Cancer Screening Market Size Share by Players in 2015
Figure India Cancer Screening Market Size Share by Players in 2016
Figure Southeast Asia Cancer Screening Market Size and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Screening Market Size by Players (2012-2017)
Figure Southeast Asia Cancer Screening Market Size Share by Players in 2015
Figure Southeast Asia Cancer Screening Market Size Share by Players in 2016
Figure Global Cancer Screening Market Size (Value) by Regions (2017-2022)
Table Global Cancer Screening Market Size by Regions (2017-2022)
Figure Global Cancer Screening Market Size Share by Regions in 2017
Figure Global Cancer Screening Market Size Share by Regions in 2021

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *